APLMW vs. ATNFW, SXTPW, DRTSW, WENAW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGW
Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.
Apollomics vs.
180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, community ranking, institutional ownership, dividends, risk, profitability, media sentiment and valuation.
180 Life Sciences and Apollomics both received 0 outperform votes by MarketBeat users.
In the previous week, 180 Life Sciences had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Apollomics. 180 Life Sciences' average media sentiment score of 1.38 beat Apollomics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
Summary
180 Life Sciences beats Apollomics on 2 of the 2 factors compared between the two stocks.
Get Apollomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
APLMW vs. The Competition
Apollomics Competitors List
Related Companies and Tools
This page (NASDAQ:APLMW) was last updated on 2/22/2025 by MarketBeat.com Staff
Free APLMW Stock Alerts